الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 121 |  |  |
| | | from | 121 | | |
Abstract
1- ugustin A: Upcoming therapeutic advances in diabetic macular edema: An intravitreal dexamethasone drug delivery system. Expert opinion on drug delivery.2011; 8 (2): 271-279.
2- Nguyen, Q.D., Brown, D.M., Marcus, D.M., Boyer, D.S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A.C., Hopkins, J.J. and Rubio, R.G.,: Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology, 2012; 119(4):789-801
3- Diabetic Retinopathy Clinical Research Network: Three-Year Follow- up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Archives of Ophthalmology. 2009; 127(3): 245-251.
4- Pescosolido N, Barbato A, Stefanucci A, and Buomprisco G: Role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy .Journal of Diabetes Research, 2015:1-8.
5- Remington LA: Retina .In Remington LA .Clinical anatomy and physiology of the visual system, 3rd ed, St Louis, Elsevier, 2012; Ch.4, 84- 88.
6- Whitehead A.J., Mares J.A., Danis R.P.: Macular Pigment. Arch Ophthalmol .2006; 124:1038-1045.
7- la Cour M, Ehinger B: The Retina. The biology of the eye, Fischbarg J, editor. Amsterdam, the Netherlands, Elsevier, 2006; 195-252.
8- Cohen AI: The retina. In Hart MJ Jr, editor: Adler’s physiology of the eye, 9th ed, St. Louis, 1992, Mosby, 579.